NASDAQ

IPO

Euda seeks Nasdaq listing via spac to gain better opportunities in healthcare market

Euda Health is listing on Nasdaq to revolutionise the traditional healthcare industry.
A cathartic and healthy correction for US tech? - THE EDGE SINGAPORE

Global Markets

A cathartic and healthy correction for US tech?

There is ongoing digital transformation strength even in the face of macro pressures.

US stocks

After meltdown, tech-bottom signals have yet to scream 'buy now'

"It’s hard to be patient when there's been so much carnage. But the pain should end, possibly soon."
Grab narrows loss by 35% to US$435 million in 1QFY2022 - THE EDGE SINGAPORE

Results

Grab narrows loss by 35% to US$435 million in 1QFY2022

Revenue in 1QFY2022 stood at US$228 million, a 6% growth y-o-y and 87% growth q-o-q.

Global Markets

U.S. Stocks Extend Losses in Late Session Selloff: Markets Wrap

Nasdaq and S&P500 continued to fall on Monday May 16
Tech stocks are in a bear market, but they aren't cheap - THE EDGE SINGAPORE

Tech

Tech stocks are in a bear market, but they aren't cheap

They’re a lot cheaper but not cheap yet.

US stocks

Nasdaq's Friedman sees IPO revival led by digital innovators

Friedman has been diversifying Nasdaq’s revenue stream to make it less reliant on the market for growth.

US stocks

Nasdaq 100 loses US$1 trillion in value — again

"It's too early to turn positive on US tech stocks." - Edmund Shing of BNP Paribas Wealth

Broker's Calls

Sell-off in share price unwarranted, Citi keeps 'buy' on Grab while DBS maintains 'hold' call

Citi Research analysts view the sell-off as an enhanced buying opportunity.

Results

Grab's loss widens by 73% to US$1.1 billion in 4Q21

Grab's FY2021 revenue grew 44% y-o-y to US$675 million.
×